Human TRIM29/ATDC ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_012101.4)

Cat. No.: pGMPC000565
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human TRIM29/ATDC Non-Viral expression plasmid (overexpression vector) for mouse TRIM29 overexpression in unique cell transient transfection and stable cell line development.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMPC000565
Gene Name TRIM29
Accession Number NM_012101.4
Gene ID 23650
Species Human
Product Type Mammalian (Non-Viral Vector) plasmid (overexpression)
Insert Length 1767 bp
Gene Alias ATDC
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Amplicin
ORF Nucleotide Sequence ATGGAAGCTGCAGATGCCTCCAGGAGCAACGGGTCGAGCCCAGAAGCCAGGGATGCCCGGAGCCCGTCGGGCCCCAGTGGCAGCCTGGAGAATGGCACCAAGGCTGACGGCAAGGATGCCAAGACCACCAACGGGCACGGCGGGGAGGCAGCTGAGGGCAAGAGCCTGGGCAGCGCCCTGAAGCCAGGGGAAGGTAGGAGCGCCCTGTTCGCGGGCAATGAGTGGCGGCGACCCATCATCCAGTTTGTCGAGTCCGGGGACGACAAGAACTCCAACTACTTCAGCATGGACTCTATGGAAGGCAAGAGGTCGCCGTACGCAGGGCTCCAGCTGGGGGCTGCCAAGAAGCCACCCGTTACCTTTGCCGAAAAGGGCGAGCTGCGCAAGTCCATTTTCTCGGAGTCCCGGAAGCCCACGGTGTCCATCATGGAGCCCGGGGAGACCCGGCGGAACAGCTACCCCCGGGCCGACACGGGCCTTTTTTCACGGTCCAAGTCCGGCTCCGAGGAGGTGCTGTGCGACTCCTGCATCGGCAACAAGCAGAAGGCGGTCAAGTCCTGCCTGGTGTGCCAGGCCTCCTTCTGCGAGCTGCATCTCAAGCCCCACCTGGAGGGCGCCGCCTTCCGAGACCACCAGCTGCTCGAGCCCATCCGGGACTTTGAGGCCCGCAAGTGTCCCGTGCATGGCAAGACGATGGAGCTCTTCTGCCAGACCGACCAGACCTGCATCTGCTACCTTTGCATGTTCCAGGAGCACAAGAATCATAGCACCGTGACAGTGGAGGAGGCCAAGGCCGAGAAGGAGACGGAGCTGTCATTGCAAAAGGAGCAGCTGCAGCTCAAGATCATTGAGATTGAGGATGAAGCTGAGAAGTGGCAGAAGGAGAAGGACCGCATCAAGAGCTTCACCACCAATGAGAAGGCCATCCTGGAGCAGAACTTCCGGGACCTGGTGCGGGACCTGGAGAAGCAAAAGGAGGAAGTGAGGGCTGCGCTGGAGCAGCGGGAGCAGGATGCTGTGGACCAAGTGAAGGTGATCATGGATGCTCTGGATGAGAGAGCCAAGGTGCTGCATGAGGACAAGCAGACCCGGGAGCAGCTGCATAGCATCAGCGACTCTGTGTTGTTTCTGCAGGAATTTGGTGCATTGATGAGCAATTACTCTCTCCCCCCACCCCTGCCCACCTATCATGTCCTGCTGGAGGGGGAGGGCCTGGGACAGTCACTAGGCAACTTCAAGGACGACCTGCTCAATGTATGCATGCGCCACGTTGAGAAGATGTGCAAGGCGGACCTGAGCCGTAACTTCATTGAGAGGAACCACATGGAGAACGGTGGTGACCATCGCTATGTGAACAACTACACGAACAGCTTCGGGGGTGAGTGGAGTGCACCGGACACCATGAAGAGATACTCCATGTACCTGACACCCAAAGGTGGGGTCCGGACATCATACCAGCCCTCGTCTCCTGGCCGCTTCACCAAGGAGACCACCCAGAAGAATTTCAACAATCTCTATGGCACCAAAGGTAACTACACCTCCCGGGTCTGGGAGTACTCCTCCAGCATTCAGAACTCTGACAATGACCTGCCCGTCGTCCAAGGCAGCTCCTCCTTCTCCCTGAAAGGCTATCCCTCCCTCATGCGGAGCCAAAGCCCCAAGGCCCAGCCCCAGACTTGGAAATCTGGCAAGCAGACTATGCTGTCTCACTACCGGCCATTCTACGTCAACAAAGGCAACGGGATTGGGTCCAACGAAGCCCCATGA
ORF Protein Sequence MEAADASRSNGSSPEARDARSPSGPSGSLENGTKADGKDAKTTNGHGGEAAEGKSLGSALKPGEGRSALFAGNEWRRPIIQFVESGDDKNSNYFSMDSMEGKRSPYAGLQLGAAKKPPVTFAEKGELRKSIFSESRKPTVSIMEPGETRRNSYPRADTGLFSRSKSGSEEVLCDSCIGNKQKAVKSCLVCQASFCELHLKPHLEGAAFRDHQLLEPIRDFEARKCPVHGKTMELFCQTDQTCICYLCMFQEHKNHSTVTVEEAKAEKETELSLQKEQLQLKIIEIEDEAEKWQKEKDRIKSFTTNEKAILEQNFRDLVRDLEKQKEEVRAALEQREQDAVDQVKVIMDALDERAKVLHEDKQTREQLHSISDSVLFLQEFGALMSNYSLPPPLPTYHVLLEGEGLGQSLGNFKDDLLNVCMRHVEKMCKADLSRNFIERNHMENGGDHRYVNNYTNSFGGEWSAPDTMKRYSMYLTPKGGVRTSYQPSSPGRFTKETTQKNFNNLYGTKGNYTSRVWEYSSSIQNSDNDLPVVQGSSSFSLKGYPSLMRSQSPKAQPQTWKSGKQTMLSHYRPFYVNKGNGIGSNEAP

Reference




    Data / case study


    Click to get more Data / Case study about the product.







    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.